GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Infinium Pharmachem INFINIUM.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

269.95

-3.30%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹1.56bn

FY2020FY2025

Net income

₹81.5m

FY2020FY2025

Free cash flow

−₹411.8m

FY2020FY2025

Shareholders' equity

₹1.09bn

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Revenue₹1.56bn₹1.36bn₹1.14bn₹991.2m₹705.3m₹388.4m
Gross profit₹368.0m₹314.1m₹336.5m₹223.8m₹156.7m₹87.0m
Operating income₹159.2m₹158.6m₹147.1m₹94.0m₹43.0m₹19.0m
Net income₹81.5m₹113.0m₹94.9m₹61.1m₹27.2m₹9.3m
Diluted earnings per share5.608.129.334.391.961.34

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets₹1.98bn₹854.5m₹706.1m₹590.0m₹341.8m₹224.5m
Cash and short-term investments₹348.4m₹119.1m₹59.8m₹54.5m₹19.9m₹8.6m
Total liabilities₹889.2m₹266.7m₹480.5m₹459.0m₹271.6m₹182.0m
Debt₹518.5m₹112.4m₹292.4m₹225.2m₹47.2m₹32.0m
Shareholders' equity₹1.09bn₹587.8m₹225.6m₹131.0m₹70.2m₹42.5m
Shares outstanding15m14m10m14m14m7m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−₹291.2m−₹130.4m₹85.9m₹118.0m₹72.9m₹30.3m
Capital spending−₹120.5m−₹38.0m−₹74.7m−₹71.8m−₹50.8m−₹11.1m
Free cash flow−₹411.8m−₹168.4m₹11.2m₹46.1m₹22.1m₹19.3m

Latest quarters

By quarter end

Sept 2025Mar 2025Sept 2024Mar 2024Sept 2023Mar 2023Sept 2022
Revenue₹840.5m₹727.3m₹829.8m₹741.6m₹614.8m₹1.14bn₹792.8m
Gross profit₹205.2m₹201.2m₹179.9m₹157.7m₹167.7m₹336.5m₹182.3m
Operating income₹88.9m₹61.6m₹69.6m₹68.4m₹90.2m₹147.1m₹82.4m
Net income₹56.0m₹37.4m₹44.1m₹50.9m₹62.1m₹94.9m₹55.1m
Diluted earnings per share3.592.463.173.664.469.333.96
Cash from operations₹22.0m−₹387.0m₹96.0m₹26.0m−₹157.0m₹66.0m₹19.0m
Capital spending−₹48.0m₹40.0m−₹161.0m−₹20.0m−₹17.0m−₹41.0m−₹32.0m
Free cash flow−₹26.0m−₹347.0m−₹65.0m₹6.0m−₹174.0m₹25.0m−₹13.0m
Total assets₹1.90bn₹1.98bn₹1.34bn₹854.5m₹1.02bn₹706.1m₹707.6m
Cash and short-term investments₹148.9m₹348.4m₹157.5m₹119.1m₹127.6m₹59.8m₹48.3m
Debt₹136.4m₹100.0m₹189.6m₹78.1m₹90.1m₹100.6m₹247.6m
Shareholders' equity₹1.15bn₹1.09bn₹631.9m₹587.8m₹539.2m₹225.6m₹185.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.2%32.0%—
Operating income19.2%52.9%—
Net income10.1%54.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin23.4%24.6%24.2%—
Operating margin10.9%11.1%10.1%—
Net margin6.7%6.9%6.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings39.836.925.2
Price to sales2.13.12.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 13 Sept 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.